Tzield Approved to Delay Onset of Stage 3 Type 1 Diabetes
Tzield is anti-CD3 monoclonal antibody that has been shown to preserve beta cell function, reducing the need for exogenous insulin.
Diabetes
Chronic Kidney Disease Incidence Differs by Race in People With Diabetes
Incidence lower in White patients vs Black, Hispanic, and indigenous populations.
Insulin Rationing Reported by 16.5 Percent of Insulin Users
Variation seen among subgroups, with rationing in 11.2% of those aged 65 years and older and 20.4% of younger persons.
Can SGLT2 and GLP1 Agents Be Cost-Effective First-Line Treatments for Diabetes?
Researchers evaluate the lifetime cost-effectiveness of using SGLT2 inhibitors or GLP1 receptor agonists as first-line treatments for type 2 diabetes.
SGLT-2 Inhibitors Show Benefit in Heart Failure With Preserved Ejection Fraction
Investigators conducted a meta-analysis of randomized controlled trials on the effect of SGLT-2 inhibitors on patients with HFpEF.
Effects of Weight Loss Methods Examined by Baseline Body Weight
Unlike people with obesity, lean individuals may not experience health benefits with intentional weight loss.
Bionic Pancreas Bests Standard Care for Glycemic Control in Type 1 Diabetes
Researchers compare the reduction in glycated hemoglobin level with use of a bionic pancreas compared with standard care in children and adults with type 1 diabetes.
FDA Warns of Cybersecurity Risk With Certain Medtronic Insulin Pumps
Equipment issue may allow someone to break in and cause the pump to deliver too much or too little insulin to the patient.
Interdisciplinary Panel Issues Consensus Document for Managing Hyperkalemia
A committee of nephrologists and cardiologists developed 6 recommendations to improve hyperkalemia management.
Obesity, Weight Gain in GDM Pregnancies Linked to ADHD in Offspring
Maternal obesity with excessive weight gain linked to increased risk for ADHD in offspring vs normal weight without excessive weight gain.
- Loading...
Loading...
Next post in ADHD Information Center
Loading... 
Loading...